Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
1 point
The law here is inconsequential. The only protection that is certain is for the data not to exist.
-1 points
0 points
1 point
Yes. The issue you pointed to is being investigated after all. And there are potential damages if they are found to be violating the law.